Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

GLOBAL MARKETS-Vaccine progress injects optimism into global stocks

Published 11/10/2020, 08:22 AM
Updated 11/10/2020, 08:30 AM
© Reuters
GBP/USD
-
XAU/USD
-
US500
-
DJI
-
AXJO
-
JP225
-
HK50
-
GC
-
HK50
-
IXIC
-
US10YT=X
-
VIX
-
MIAPJ0000PUS
-
DXY
-
BNTX
-

By Lawrence Delevingne
BOSTON, Nov 9 (Reuters) - Global stocks and oil jumped and
Treasuries sold off on Monday as progress in the development of
a coronavirus vaccine lifted investor confidence in a world
economic recovery.
"Preliminary trials have caused markets to come alive, not
that they needed much encouragement," Chris Weston,
Pepperstone's Melbourne-based head of research, wrote in a note
Monday.
Pfizer Inc PFE.N said its COVID-19 vaccine, developed with
German partner BioNTech SE BNTX.O , was more than 90% effective
in preventing infection, marking the first successful results
from a large-scale clinical trial. On Wall Street, the Dow Jones Industrial Average .DJI rose
2.95%, the S&P 500 .SPX gained 1.17% while the Nasdaq
Composite .IXIC dropped 1.53%. E-mini futures for the S&P 500
EScv1 rose 0.47%.
Japan's Nikkei 225 .N225 rose 1.5% to a 29-year high in
early trade and Australia's S&P/ASX 200 .AXJO rose 1.4%. Hong
Kong's Hang Seng index futures .HSI HSIc1 rose 1.85%. MSCI's
broadest index of Asia-Pacific shares outside Japan
.MIAPJ0000PUS closed 0.12% higher.
Pfizer's announcement jolted European shares to an
eight-month high, building on expectations of more stable trade
policies following the U.S. election. While stocks have also rallied on the assumption that
Democrat Joe Biden would be the next U.S. President, the top
Republican in U.S. Congress on Monday did not acknowledge Biden
as president-elect, raising concerns about a rough transition of
power.
Senator Mitch McConnell said in a speech that President
Donald Trump was well within his rights to look into charges of
election "irregularities" but did not offer any evidence of
fraud. The dollar index .DXY rose 0.65%, but Joseph Capurso, a
strategist with Commonwealth Bank of Australia in Sydney,
expects the move to be short-lived.
"As a counter cyclical currency, the USD falls against most
currencies as the global economy improves, with the exception of
the JPY," Capurso wrote. He noted modeling suggested the dollar
was "significantly undervalued" against the yen.
The Australian dollar fell 0.07% versus the greenback at
$0.728.
The Japanese yen strengthened 0.25% versus the greenback to
105.09 per dollar, while Sterling GBP= was last trading at
$1.3171, up 0.06% on the day.
The vaccine news also sent long-dated U.S. Treasury yields
sky-rocketing in their biggest one-day jump since March. The
yield curve, an indication of risk appetite, hit its steepest
level since March. Benchmark 10-year notes US10YT=RR last fell 31/32 in price
to yield 0.9235%, from 0.82% late on Friday.
The CBOE Market Volatility index .VIX , a barometer of
investor anxiety, hit its lowest closing level since late
August.
Oil prices surged, posting their biggest daily percentage
gain in more than five months as the vaccine news and an OPEC
output deal fueled optimism about rebounding demand.
Gold prices slumped as investors pivoted away from the
safe-haven metal in favor of riskier assets. Spot gold XAU= added 0.4% to $1,868.68 an ounce.


<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Global assets http://tmsnrt.rs/2jvdmXl
Global currencies vs. dollar http://tmsnrt.rs/2egbfVh
Emerging markets http://tmsnrt.rs/2ihRugV
MSCI All Country Wolrd Index Market Cap http://tmsnrt.rs/2EmTD6j
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.